Table 1. Characterization of the evaluated cohort and the correlation of the presence of lymph node lymph vessels (nLV+) with clinicopathological parameters.
| Variable | Numbers | Detectable LVD in lymph nodes (nLV+) | p-value |
| Sex | 0.4052 (Pearson) | ||
| Male | 148 (73%) | 71 (47%) | |
| Female | 55 (27%) | 30 (55%) | |
| Age, years | 0.7188 (Pearson) | ||
| ≤70 | 112 (55%) | 57 (51%) | |
| >70 | 91 (45%) | 44 (48%) | |
| yUICC stage | 0.0026 (Pearson) | ||
| 0 | 10 (5%) | 3 (30%) | |
| I | 66 (33%) | 22 (33%) | |
| IIA | 58 (29%) | 31 (53%) | |
| IIB | 3 (1%) | 1 (33%) | |
| IIC | 1 | 1 (100%) | |
| IIIA | 9 (4%) | 8 (89%) | |
| IIIB | 32 (16%) | 17 (53%) | |
| IIIC | 5 (2%) | 5 (100%) | |
| IVA | 19 (9%) | 13 (68%) | |
| Relapse | 0.0171 (Pearson) | ||
| yes | 46 (23%) | 30 (65%) | |
| No | 157 (77%) | 71 (45%) |